The JI PBL Intereron Source
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lassmann, S.
Right arrow Articles by Campbell, I. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lassmann, S.
Right arrow Articles by Campbell, I. L.
The Journal of Immunology, 2001, 167: 5485-5493.
Copyright © 2001 by The American Association of Immunologists

Induction of Type 1 Immune Pathology in the Brain Following Immunization Without Central Nervous System Autoantigen in Transgenic Mice With Astrocyte-Targeted Expression of IL-121

Silke Lassmann2, Carrie Kincaid, Valérie C. Asensio3 and Iain L. Campbell4

Department of Neuropharmacology, The Scripps Research Institute, La Jolla, CA 92037 Department of Neuropharmacology, The Scripps Research Institute, La Jolla, CA 92037

IL-12, a cytokine produced by microglia, may regulate cellular immunity at a localized level in the CNS. To investigate this further, we examined the consequences of peripheral immune stimulation without specific autoantigen in wild-type or transgenic (termed GF-IL12) mice with astrocyte production of the bioactive IL-12 p75 heterodimer. Active immunization with CFA and pertussis toxin, a procedure known to stimulate a robust type 1-biased immune response, produced CNS immune pathology from which GF-IL12 but not wild-type mice developed signs of clinical disease consisting of loss of activity, piloerection, mild tremor, and motor change. All immunized mice had some degree of mononuclear cell infiltration into the brain; however, the severity of this was markedly increased in GF-IL12 mice where leukocytes accumulated in perivascular and parenchymal locations. Accumulating cells consisted of CD4+ and CD8+ T cells and macrophage/microglia. Moreover, expression of cytokines (IFN-{gamma} and TNF), chemokines (IFN-inducible protein-10 and RANTES), the immune accessory molecules, MHC class II, B7.2, ICAM-1 and VCAM-1, and NO synthase-2 was induced in the CNS of the GF-IL12 mice. Therefore, peripheral immunization of GF-IL12 but not wild-type mice can provoke active type 1 immunity in the brain—a process that does not require CNS-specific immunizing autoantigen. These findings indicate that the cytokine milieu of a tissue can dramatically influence the development of intrinsic immune responses and associated pathology.




This article has been cited by other articles:


Home page
Am. J. Pathol.Home page
L. Visser, M.-J. Melief, D. van Riel, M. van Meurs, E. A. Sick, S. Inamura, J. J. Bajramovic, S. Amor, R. Q. Hintzen, L. A. Boven, et al.
Phagocytes Containing a Disease-Promoting Toll-Like Receptor/Nod Ligand Are Present in the Brain during Demyelinating Disease in Primates
Am. J. Pathol., November 1, 2006; 169(5): 1671 - 1685.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
H. Takase, C.-R. Yu, D.-I. Ham, C.-C. Chan, J. Chen, B. P. Vistica, E. F. Wawrousek, S. K. Durum, C. E. Egwuagu, and I. Gery
Inflammatory processes triggered by TCR engagement or by local cytokine expression: differences in profiles of gene expression and infiltrating cell populations
J. Leukoc. Biol., September 1, 2006; 80(3): 538 - 545.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
H. Kimura, S.-C. Tzou, R. Rocchi, M. Kimura, K. Suzuki, A. F. Parlow, N. R. Rose, and P. Caturegli
Interleukin (IL)-12-Driven Primary Hypothyroidism: the Contrasting Roles of Two Th1 Cytokines (IL-12 and Interferon-{gamma})
Endocrinology, August 1, 2005; 146(8): 3642 - 3651.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
M. Hofer, J. Hausmann, P. Staeheli, and A. Pagenstecher
Cerebral Expression of Interleukin-12 Induces Neurological Disease via Differential Pathways and Recruits Antigen-Specific T Cells in Virus-Infected Mice
Am. J. Pathol., September 1, 2004; 165(3): 949 - 958.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
D. Huang, M. Tani, J. Wang, Y. Han, T. T. He, J. Weaver, I. F. Charo, V. K. Tuohy, B. J. Rollins, and R. M. Ransohoff
Pertussis Toxin-Induced Reversible Encephalopathy Dependent on Monocyte Chemoattractant Protein-1 Overexpression in Mice
J. Neurosci., December 15, 2002; 22(24): 10633 - 10642.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
O. Stuve, S. Youssef, A. J. Slavin, C. L. King, J. C. Patarroyo, D. L. Hirschberg, W. J. Brickey, J. M. Soos, J. F. Piskurich, H. A. Chapman, et al.
The Role of the MHC Class II Transactivator in Class II Expression and Antigen Presentation by Astrocytes and in Susceptibility to Central Nervous System Autoimmune Disease
J. Immunol., December 15, 2002; 169(12): 6720 - 6732.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
S. Freude, J. Hausmann, M. Hofer, N. Pham-Mitchell, I. L. Campbell, P. Staeheli, and A. Pagenstecher
Borna Disease Virus Accelerates Inflammation and Disease Associated with Transgenic Expression of Interleukin-12 in the Central Nervous System
J. Virol., October 25, 2002; 76(23): 12223 - 12232.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. Boztug, M. J. Carson, N. Pham-Mitchell, V. C. Asensio, J. DeMartino, and I. L. Campbell
Leukocyte Infiltration, But Not Neurodegeneration, in the CNS of Transgenic Mice with Astrocyte Production of the CXC Chemokine Ligand 10
J. Immunol., August 1, 2002; 169(3): 1505 - 1515.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
T. B. Jones, D. M. Basso, A. Sodhi, J. Z. Pan, R. P. Hart, R. C. MacCallum, S. Lee, C. C. Whitacre, and P. G. Popovich
Pathological CNS Autoimmune Disease Triggered by Traumatic Spinal Cord Injury: Implications for Autoimmune Vaccine Therapy
J. Neurosci., April 1, 2002; 22(7): 2690 - 2700.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2001 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2001 by The American Association of Immunologists, Inc. All rights reserved.